tiprankstipranks
Advertisement
Advertisement
Immunovant price target raised to $43 from $32 at BofA
PremiumThe FlyImmunovant price target raised to $43 from $32 at BofA
2M ago
Immunovant price target raised to $40 from $35 at H.C. Wainwright
Premium
The Fly
Immunovant price target raised to $40 from $35 at H.C. Wainwright
2M ago
Immunovant rises 33.6%
Premium
The Fly
Immunovant rises 33.6%
2M ago
Midday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus
PremiumThe FlyMidday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus
4M ago
Buy Rating Maintained on Immunovant as IMVT-1402 Pipeline Overshadows Batoclimab Setback
Premium
Ratings
Buy Rating Maintained on Immunovant as IMVT-1402 Pipeline Overshadows Batoclimab Setback
4M ago
Immunovant price target lowered to $50 from $52 at Leerink
Premium
The Fly
Immunovant price target lowered to $50 from $52 at Leerink
4M ago
Immunovant initiated with a Market Perform at Bernstein
PremiumThe FlyImmunovant initiated with a Market Perform at Bernstein
4M ago
Undervalued Potential in Difficult-to-Treat RA: Buy Rating on Immunovant Driven by IMVT-1402’s Differentiated Profile and Underappreciated Market Opportunity
Premium
Ratings
Undervalued Potential in Difficult-to-Treat RA: Buy Rating on Immunovant Driven by IMVT-1402’s Differentiated Profile and Underappreciated Market Opportunity
5M ago
Immunovant Rides Brepocitinib Momentum Into 2026
Premium
Company Announcements
Immunovant Rides Brepocitinib Momentum Into 2026
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100